dc.contributor.author | Tunckiran, Ahmet | |
dc.contributor.author | Yuksel, Mustafa | |
dc.contributor.author | Ucar, Murat | |
dc.contributor.author | Kozacioglu, Zafer | |
dc.contributor.author | Akman, Ramazan Yavuz | |
dc.contributor.author | Ipekci, Tumay | |
dc.date.accessioned | 2021-03-05T10:09:37Z | |
dc.date.available | 2021-03-05T10:09:37Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Ipekci T., Yuksel M., Ucar M., Tunckiran A., Kozacioglu Z., Akman R. Y. , "Is Preoperative Neutrophil Lymphocyte Ratio a Reliable Prognostic Parameter for Localized Prostate Cancer?", UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, cilt.16, ss.119-122, 2017 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_a19fb36d-dca5-42e2-a8f7-f65d850d394b | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/108290 | |
dc.identifier.uri | https://doi.org/10.4274/uob.900 | |
dc.description.abstract | Objective: In spite of all efforts, prostate cancer is still the 2nd highest cause of cancer-related deaths in men. For this reason new developments are needed in diagnosis, treatment and follow-up of prostate cancer. Neutrophil/lymphocyte (N/L) ratio is a cheap and effective parameter used for research into many solid tumors; but there are not enough studies on the reliability of this parameter in prostate cancer. In this study we researched the efficacy of N/L ratio in localized prostate cancer. | |
dc.language.iso | eng | |
dc.subject | Onkoloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Is Preoperative Neutrophil Lymphocyte Ratio a Reliable Prognostic Parameter for Localized Prostate Cancer? | |
dc.type | Makale | |
dc.relation.journal | UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | |
dc.contributor.department | Antalya Training & Research Hospital , , | |
dc.identifier.volume | 16 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 119 | |
dc.identifier.endpage | 122 | |
dc.contributor.firstauthorID | 247992 | |